XML 74 R6.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Series C Preferred Stock
Series B Preferred Stock
Preferred Stock
Series C Preferred Stock
Preferred Stock
Series B Preferred Stock
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Series C Preferred Stock
Accumulated Deficit
Accumulated Other Comprehensive Income
Balance (in shares) at Dec. 31, 2018         8,000,000 449,787,000        
Balance at Dec. 31, 2018 $ 3,416,101       $ 80 $ 4,498 $ 3,623,275   $ (632,040) $ 420,288
Increase (Decrease) in Stockholders' Equity                    
Net (loss)/income 88,857               88,857  
Issuance of stock, net of expenses (in shares)           1,066,000        
Issuance of stock, net of expenses 551         $ 7 544      
Repurchase of shares of common stock (in shares) [1]           (370,000)        
Repurchase of shares of common stock [1] (2,610)           (2,610)      
Equity based compensation expense 992           992      
Accrued dividends attributable to stock-based awards 435           435      
Dividends declared on common stock ($0.20 per share) (90,097)               (90,097)  
Dividends declared on preferred stock ($0.46875 per share) (3,750)               (3,750)  
Dividends attributable to dividend equivalents (256)               (256)  
Change in unrealized gains on MBS, net 5,094                 5,094
Derivative hedging instrument fair value changes and amortization, net (10,786)                 (10,786)
Balance (in shares) at Mar. 31, 2019         8,000,000 450,483,000        
Balance at Mar. 31, 2019 3,404,531       $ 80 $ 4,505 3,622,636   (637,286) 414,596
Increase (Decrease) in Stockholders' Equity                    
Adjustments related to tax withholding for share-based compensation           $ 2,600        
Shares paid for tax withholding for share based compensation (in shares)           370,244        
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears   $ 0.12639 $ 0.46875              
Balance (in shares) at Dec. 31, 2019       0 8,000,000 452,369,000        
Balance at Dec. 31, 2019 3,383,952     $ 0 $ 80 $ 4,524 3,640,341   (631,040) 370,047
Increase (Decrease) in Stockholders' Equity                    
Net (loss)/income (908,995)               (908,995)  
Issuance of stock, net of expenses (in shares)       11,000,000   1,106,000        
Issuance of stock, net of expenses 687 $ 266,029   $ 110   $ 7 680 $ 265,919    
Repurchase of shares of common stock (in shares) [2]           (337,000)        
Repurchase of shares of common stock [2] (2,652)           (2,652)      
Equity based compensation expense 1,266           1,266      
Accrued dividends attributable to stock-based awards 1,059           1,059      
Dividends declared on preferred stock ($0.46875 per share) (5,215)                  
Change in unrealized gains on MBS, net (243,812)                 (243,812)
Derivative hedging instrument fair value changes and amortization, net (48,533)                 (48,533)
Balance (in shares) at Mar. 31, 2020       11,000,000 8,000,000 453,138,000        
Balance at Mar. 31, 2020 $ 2,440,675     $ 110 $ 80 $ 4,531 $ 3,906,613   $ (1,548,361) $ 77,702
Increase (Decrease) in Stockholders' Equity                    
Adjustments related to tax withholding for share-based compensation           $ 2,700        
Shares paid for tax withholding for share based compensation (in shares)           337,026        
[1] For the three months ended March 31, 2019, includes approximately $2.6 million (370,244 shares) surrendered for tax purposes related to equity-based compensation awards.
[2] For the three months ended March 31, 2020 includes approximately $2.7 million (337,026 shares) surrendered for tax purposes related to equity-based compensation awards.